Clinical Trial Update: Botulinum Toxin Type A and Kinesitherapy of Post-stroke Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is investigating the use of botulinum toxin type A in combination with kinesitherapy for post-stroke patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Federal University of Bahia | Conditions: Stroke | Phase 3 | Status: UNKNOWN